Replies to post #702623 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Yes, many companies do not prioritize UK launches so have no need to push the NICE schedule.

In most all cases the drug is EMA approved, the MHRA rubber stamps it then the roll out is country by country. They go to the more valuable countries like Germany or France first.

Does not apply to a company that for some insane reason only applied to the MHRA.

And on your reply to me about NICE alternative programs, they do not work in this case.

So why has LP not even started on the process?